BladderBoneBrainBreastCervicalColonEsophagealKidneyLaryngealLeukemia CancerLiverLungLymphomaMouthOvarianPancreaticProstateRectalSkinTesticularThroatUterineFood & NutritionHeart / Stroke-RelatedStroke Heart / Stroke-RelatedCardiologyFamily PracticeNeurologyInternal MedicineGeriatricsBladder CancerBone CancerBrain CancerBreast CancerCervical CancerColon CancerEsophageal CancerKidney CancerLaryngeal CancerLeukemiaLiver CancerLung CancerLymphoma CancerMouth CancerOvarian CancerPancreatic CancerProstate CancerRectal CancerSkin CancerTesticular CancerThroat CancerCancerUterine CancerCardiovascular DiseasesStrokeNutrition
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Jan. 26, 2018 (HealthDay News) -- For stroke survivors, high adherence to the MIND (Mediterranean-DASH Intervention for Neurodegenerative Delay) diet is associated with a slower rate of cognitive decline, according to a study presented at the American Stroke Association's International Stroke Conference, held from Jan. 24 to 26 in Los Angeles.
Laurel J. Cherian, M.D., from the Rush University Medical Center in Chicago, and colleagues annually assessed 106 participants with a history of stroke at baseline enrollment for an average of 4.7 years to examine whether the MIND diet slows cognitive decline. Cognition was assessed in five cognitive domains using structured clinical examinations. A valid food frequency questionnaire was used to compute MIND diet scores.
The researchers found that in an age-adjusted model, there was a positive association for the top versus the lowest tertile of MIND diet scores with a slower rate of global cognitive decline (β = 0.08; P = 0.02). The correlation remained unchanged after further adjustment for sex, education, apolipoprotein E4, late-life cognitive activity, caloric intake, physical activity, and smoking (β = 0.08; P = 0.03).
"Our study suggests that if we choose the right foods, we may be able to protect stroke survivors from cognitive decline," Cherian said in a statement. "This is a preliminary study that will hopefully be confirmed by other studies, including research looking specifically at stroke survivors."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 28, 2022
Read this Next
Other Trending Articles